Research

Medical Sciences

Title :

Tackling lung cancer drug resistance in India: An integrated drug repurposing strategies

Area of research :

Life Sciences & Biotechnology, Medical Sciences

Focus area :

Lung cancer drug resistance

Principal Investigator :

Dr. Shanthi V, Professor, Vellore Institute of Technology (VIT), Chennai, Tamil Nadu

Timeline Start Year :

2017

Contact info :

Details

Total Budget (INR):

 16,17,000

Organizations involved

Implementing Agency :

Vellore Institute of Technology (VIT), Chennai, Tamil Nadu

Funding Agency :

Science and Engineering Research Board (SERB),Department of Science & Technology (DST),Government of India

Related Research

A phase III multicentre trial of weekly induction chemotherapy followed by standard chemoradiation versus standard chemoradiation alone in patients with locally advanced cervical cancer
A prospective cohort study on Cerebro-Spinal Fluid (CSF) diversion catheter-related infections in a tertiary referral neurosurgical care center
Acemannan based nanogels to target microbicides to mucosal and sub mucosal regions of vagina to prevent HIV-1 infection
An open label, balanced, randomized clinical trial to evaluate safety & efficacy of piperine 225 mg with standard anti tubercular treatment in newly diagnosed sputum positive drug sensitive pulmonary TB adult patients in comparison with standard ..
Analysis of inflammatory mediators involve in rheumatoid arthritis which may help in defining drug targets in north Indian population for the control of the disease